Your browser doesn't support javascript.
loading
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial.
Frenel, J S; Kim, J W; Aryal, N; Asher, R; Berton, D; Vidal, L; Pautier, P; Ledermann, J A; Penson, R T; Oza, A M; Korach, J; Huzarski, T; Pignata, S; Colombo, N; Park-Simon, T W; Tamura, K; Sonke, G S; Freimund, A E; Lee, C K; Pujade-Lauraine, E.
Afiliação
  • Frenel JS; Institut de Cancerologie de l'Ouest, GINECO, GINEGEPS, Centre René Gauducheau, Saint-Herblain, France. Electronic address: jean-sebastien.frenel@ico.unicancer.fr.
  • Kim JW; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Aryal N; NHMRC CTC Centre, University of Sydney, Camperdown, Sydney, Australia.
  • Asher R; NHMRC CTC Centre, University of Sydney, Camperdown, Sydney, Australia.
  • Berton D; Institut de Cancerologie de l'Ouest, GINECO, GINEGEPS, Centre René Gauducheau, Saint-Herblain, France.
  • Vidal L; GEICO & H Clínic de Barcelona, Barcelona, Spain.
  • Pautier P; GINECO & Gustave Roussy Cancer Center, Villejuif, France.
  • Ledermann JA; NCRI & University College London, London, UK.
  • Penson RT; Massachusetts General Hospital, Boston, USA.
  • Oza AM; Princess Margaret Cancer Centre, Toronto, Canada.
  • Korach J; ISGO & Chaim Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.
  • Huzarski T; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Pignata S; MITO & Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli, Naples, Italy.
  • Colombo N; MaNGO & European Institute of Oncology IRCCS and University of Milan-Bicocca, Milano, Italy.
  • Park-Simon TW; AGO & Medical School, Department of Gynecologic Oncology, Hannover, Hannover, Germany.
  • Tamura K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Sonke GS; DGOG & Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Freimund AE; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Lee CK; NHMRC CTC Centre, University of Sydney, Camperdown, Sydney, Australia.
  • Pujade-Lauraine E; ARCAGY-GINECO, Paris, France.
Ann Oncol ; 33(10): 1021-1028, 2022 10.
Article em En | MEDLINE | ID: mdl-35772665
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article